Republicans want to abandon the bill altogether and Rep. Larry Buschon (R-Ind.) told The Hill he plans to propose a bill Friday to block the pilot.
Democrats in both the U.S. Senate and House have expressed concerns with the proposal as it exists. Democrats from the Senate Finance Committee wrote a letter to the administration expressing concerns the program could limit patient access to treatment, according to the report. House Democrats penned a similar letter expressing 11 chief concerns, including how it relates to rural providers, according to the report.
The proposal would change the way Medicare Part B reimburses providers for drugs. It currently pays providers the average price of a drug plus 6 percent. Under the proposed bill, the 6 percent would be reduced to 2.5 percent plus a $16 flat fee, according to The Hill.
HHS maintained its support for the bill despite Congressional concerns, according to the report.
More articles on finance:
Moody’s preliminary numbers show nonprofit healthcare profitability margins at multi-year high
Ochsner recognized for improvements implemented across spend and revenue cycle segments
No 2 prices the same: 13 findings on healthcare price variation across the U.S.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.